Cardlytics Historical Cash Flow

CDLX Stock  USD 3.80  0.13  3.54%   
Analysis of Cardlytics cash flow over time is an excellent tool to project Cardlytics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Inventory of 32.1 M or Stock Based Compensation of 27.1 M as it is a great indicator of Cardlytics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cardlytics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cardlytics is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

About Cardlytics Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Cardlytics balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cardlytics's non-liquid assets can be easily converted into cash.

Cardlytics Cash Flow Chart

Cardlytics reported Sale Purchase Of Stock of (40 Million) in 2023. Change To Inventory is likely to rise to about 32.1 M in 2024, despite the fact that Change In Cash is likely to grow to (28.6 M).

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Depreciation

Depreciation indicates how much of Cardlytics value has been used up. For tax purposes Cardlytics can deduct the cost of the tangible assets it purchases as business expenses. However, Cardlytics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Capital Expenditures

Capital Expenditures are funds used by Cardlytics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Cardlytics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Cardlytics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Cardlytics reported Sale Purchase Of Stock of (40 Million) in 2023. Change To Inventory is likely to rise to about 32.1 M in 2024, despite the fact that Change In Cash is likely to grow to (28.6 M).
 2021 2022 2023 2024 (projected)
Other Non Cash Items18.7M335.7M77.5M60.4M
Depreciation35.7M43.7M29.5M16.8M

Cardlytics cash flow statement Correlations

0.26-0.1-0.140.49-0.18-0.070.630.38-0.180.37-0.820.560.030.5-0.160.25-0.97-0.79-0.180.630.96
0.260.030.060.770.2-0.230.680.70.380.92-0.360.07-0.460.710.67-0.5-0.29-0.11-0.440.830.05
-0.10.030.73-0.040.60.09-0.35-0.39-0.48-0.090.080.020.50.44-0.340.320.220.120.81-0.01-0.21
-0.140.060.730.090.05-0.07-0.01-0.05-0.11-0.030.44-0.340.10.55-0.15-0.070.090.460.63-0.14-0.19
0.490.77-0.040.09-0.12-0.570.830.890.530.84-0.38-0.12-0.640.770.62-0.54-0.54-0.12-0.50.740.28
-0.180.20.60.05-0.12-0.02-0.47-0.4-0.52-0.05-0.170.070.580.050.050.120.34-0.050.270.19-0.32
-0.07-0.230.09-0.07-0.57-0.02-0.35-0.57-0.47-0.140.020.670.47-0.29-0.640.740.15-0.20.47-0.30.05
0.630.68-0.35-0.010.83-0.47-0.350.920.570.78-0.430.08-0.70.680.46-0.46-0.74-0.29-0.570.730.54
0.380.7-0.39-0.050.89-0.4-0.570.920.760.79-0.27-0.2-0.840.580.7-0.7-0.51-0.06-0.70.660.26
-0.180.38-0.48-0.110.53-0.52-0.470.570.760.510.15-0.42-0.980.170.67-0.730.040.28-0.60.25-0.23
0.370.92-0.09-0.030.84-0.05-0.140.780.790.51-0.420.18-0.590.680.57-0.39-0.4-0.2-0.470.790.18
-0.82-0.360.080.44-0.38-0.170.02-0.43-0.270.15-0.42-0.72-0.07-0.350.09-0.30.710.950.23-0.78-0.74
0.560.070.02-0.34-0.120.070.670.08-0.2-0.420.18-0.720.370.07-0.550.75-0.43-0.850.190.350.59
0.03-0.460.50.1-0.640.580.47-0.7-0.84-0.98-0.59-0.070.37-0.28-0.690.730.12-0.220.66-0.330.09
0.50.710.440.550.770.05-0.290.680.580.170.68-0.350.07-0.280.23-0.23-0.52-0.160.050.710.32
-0.160.67-0.34-0.150.620.05-0.640.460.70.670.570.09-0.55-0.690.23-0.910.060.36-0.770.41-0.32
0.25-0.50.32-0.07-0.540.120.74-0.46-0.7-0.73-0.39-0.30.750.73-0.23-0.91-0.09-0.520.65-0.240.35
-0.97-0.290.220.09-0.540.340.15-0.74-0.510.04-0.40.71-0.430.12-0.520.06-0.090.680.28-0.6-0.95
-0.79-0.110.120.46-0.12-0.05-0.2-0.29-0.060.28-0.20.95-0.85-0.22-0.160.36-0.520.680.08-0.58-0.79
-0.18-0.440.810.63-0.50.270.47-0.57-0.7-0.6-0.470.230.190.660.05-0.770.650.280.08-0.41-0.13
0.630.83-0.01-0.140.740.19-0.30.730.660.250.79-0.780.35-0.330.710.41-0.24-0.6-0.58-0.410.45
0.960.05-0.21-0.190.28-0.320.050.540.26-0.230.18-0.740.590.090.32-0.320.35-0.95-0.79-0.130.45
Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash44.7M188.8M(59.8M)(111.6M)(30.2M)(28.6M)
Net Borrowings(46.8M)196.2M(200K)(209K)(240.4K)(228.3K)
Stock Based Compensation15.9M32.4M50.3M44.7M41.0M27.1M
Free Cash Flow437K(17.7M)(51.1M)(67.4M)(12.6M)(13.2M)
Change In Working Capital4.6M(3.8M)(6.7M)(11.3M)(13.5M)(12.8M)
Begin Period Cash Flow59.9M104.6M293.3M233.6M122.0M114.4M
Total Cashflows From Investing Activities(11.0M)(10.1M)(506.7M)(15.8M)(14.2M)(14.9M)
Other Cashflows From Financing Activities(339K)(10.1M)(390K)(331K)(50.1M)(47.5M)
Depreciation4.5M11.6M35.7M43.7M29.5M16.8M
Other Non Cash Items3.6M6.4M18.7M335.7M77.5M60.4M
Capital Expenditures11.0M10.1M12.6M13.5M12.4M9.5M
Total Cash From Operating Activities11.5M(7.6M)(38.5M)(53.9M)(185K)(194.3K)
Change To Account Receivables(26.0M)(2.4M)(27.9M)(4.5M)(7.7M)(8.1M)
Change To Operating Activities31.2M(1.4M)23.8M(5.9M)(6.8M)(6.4M)
Net Income(17.1M)(55.4M)(128.6M)(465.3M)(134.7M)(141.4M)
Total Cash From Financing Activities44.2M206.4M486.0M(40.0M)(20.0M)(19.0M)
End Period Cash Flow104.6M293.3M233.6M122.0M91.8M119.4M
Change To Netincome16.5M32.6M46.8M377.3M433.9M455.6M
Change To Liabilities5.6M(1.2M)1.3M(10.4M)(9.4M)(8.9M)
Investments(11.0M)(10.1M)(506.7M)(15.8M)(10.1M)(10.6M)
Change Receivables(26.0M)(2.4M)(27.9M)(4.5M)(5.2M)(5.5M)
Cash And Cash Equivalents Changes44.6M188.7M(59.2M)(109.7M)(98.7M)(93.8M)
Cash Flows Other Operating28.1M8.5M31.4M11.4M13.1M16.5M
Issuance Of Capital Stock91.2M10.2M486.4M379K55K52.3K
Other Cashflows From Investing Activities(2.7M)(4.7M)(503.6M)(14.6M)(13.1M)(13.8M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.